SEBI nods its approval to Fosun-owned Gland Pharma to make market debut with Rs 6000 crores IPO. The company filed the draft red herring prospectus (DRHP) with the market regulator in July has received the final approval. It’s going to be the first Chinese company to list in Indian bourses. Gland Pharma is backed by …
Investors are rushing to stake a claim on Ant Group IPO when it makes a debut in November. Founder of Ant Group and affiliate Alibaba Group Holding, billionaire Jack Ma said that he is amazed to see such enthusiasm from investors. In the world’s largest, Ant Group IPO aims to raise USD 34.4 billion, surpassing …
Gland Pharma, the Hyderabad-based pharmaceutical company that launched its IPO on November 9, finalised the allotment status on November 17. If you have applied for the IPOs, you can check gland pharma IPO allotment status online by visiting the registrar’s website or in the BSE web portal. But before you check the allotment status, let’s …
The COVID-19 pandemic sweeping across the world has caught everyone unawares. No one among the policymakers, businesses and the larger public was prepared to deal with the highly infectious disease. Without any available treatment, governments reacted by shutting down large parts of the economy to stop the spread of the novel coronavirus that causes the …
In the latest development, leading online used car seller Vroom has filed to go public. It plans to list in Nasdaq Global Market under the symbol, VRM. Vroom’s rival Carvana Co. went public in 2017. Vroom’s profit in the recent quarter increased by 160 percent after online trade surged amid the CoronaVirus outbreak and customers …
The Government of India has agreed to launch an IPO of the shares of LIC (Life Insurance Corporation of India). Given the size of the corporation and the fact that it is the largest life insurer in India, the LIC IPO launch is expected to be the most significant IPO launch in recent time. Moving ahead with …
Rossari Biotech, a specialty industrial chemical manufacturer, readies itself to launch Rs 500 crore worth of fresh IPO equities. It is the first in the last four months since SBI Card & Payment announced IPO launch on March 5, before nationwide lockdown commenced in the wake of COVID-19 outbreak in the country. The IPO will …
Hyderabad based pharmaceutical company, Gland Pharma targets to raise capital funds worth Rs 6000 – Rs 7000 crores in IPO share launch. In its red herring prospectus filing with SEBI, the company has mentioned that IPO launch will include fresh scrips as well as offer for sale from promoters. Gland Pharma has Chinese parents. Fosun …
After several weeks of hiatus caused by nationwide lockdown following COVID-19 outbreak, some actions are returning to the Indian stock market. Companies are returning to the market with their IPO offers to entice investors once more. After the announcements of IPO share launch by Rossari Biotech and Gland Pharma, the stage is now ready for …
It is a good sign for the market that more companies are coming up with IPO share launch proposals. The capital market suffered a nosedive when investors went for a frenzied selling spree as cases of COVID-19 started to surface in India. The last big company to announce an IPO share launch was SBI Cards …
